Effects of Apolipoprotein E-ε4 and -Ε2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P
Amy R. Borenstein,James A. Mortimer,Ding,Gerard D. Schellenberg,Charles DeCarli,Qianhua Zhao,Cathleen Copenhaver,Qihao Guo,Shugang Chu,Douglas Galasko,David P. Salmon,Qi Dai,Yougui Wu,Ronald Petersen,Zhen Hong
DOI: https://doi.org/10.1177/1533317509357736
2010-01-01
American Journal of Alzheimer s Disease & Other Dementias®
Abstract:Objective: To determine apolipoprotein E (APOE)-ε4 and -ε2 frequencies and risk of mild cognitive impairment (MCI) and dementia in Shanghai, China. Methods: A total of 34 MCI and 34 dementia cases were recruited from an urban Memory Disorders Clinic and 32 controls were recruited from a residential community served by the clinic. Apolipoprotein E was genotyped using standard methods. Results: Among controls, frequencies were ε2, 0.11; ε3, 0.84; and ε4, 0.05; among MCI, 0.05, 0.77, and 0.18; and for dementia, 0.02, 0.84, and 0.15, respectively. In education-adjusted models, the odds ratio (OR) = 5.6 for dementia (95% CI = 1.09-29.3) and 4.7 for MCI (95% CI = 0.90-25.2) associated with any ε4 allele. The ε2 allele was inversely associated with dementia (OR = 0.12, 95% CI = 0.013-0.997) and MCI (OR = 0.38, 95% CI = 0.08-1.61). Conclusions: APOE-ε4 increases and -ε2 decreases the risk of dementia vs normal cognition. Similar trends were observed for amnestic mild cognitive impairment (aMCI).